CymitQuimica logo

Busulfan

CAS:

Ref. 3D-FB19365

100g
341.00€
250g
487.00€
500g
669.00€
Busulfan
Biosynth

    Product Information

    Name:Busulfan
    Synonyms:
    • 1,4-Butanediol-dimethanesulfonate estersBusulphanCB-2041
    Brand:Biosynth
    Description:Busulfan is a chemotherapy drug that is used to treat certain cancers and blood disorders. Busulfan is administered intravenously as an injection solution, which may be given over 1 to 4 hours depending on the dose. Busulfan has a concentration-time curve with a rapid onset of action and short duration of action. The elimination half-life is about 2 hours. Busulfan has been shown to have immunosuppressive effects in experimental models of autoimmune diseases and hyperproliferative diseases such as lymphomas and myelogenous leukemia. The mechanism of this effect is not known, but it may be due to inhibition of IL-2 receptor binding or inhibition of the polymerase chain reaction (PCR).
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:246.3 g/mol
    Formula:C6H14O6S2
    Purity:Min. 95%
    Color/Form:Powder
    InChI:InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
    InChI key:InChIKey=COVZYZSDYWQREU-UHFFFAOYSA-N
    SMILES:CS(=O)(=O)OCCCCOS(C)(=O)=O

    Technical inquiry about: Busulfan

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.